Pharma

• Pantherna and WACKER Strengthen Collaboration for mRNA Biopharmaceutical Development and Production in Halle, Germany
• Roquette makes strategic move by signing agreement to acquire IFF Pharma Solutions
• Daiichi Sankyo invests approximately one billion euros in expanding its site into an international innovation center in Pfaffenhofen, Bavaria, Germany
• PanTera signs agreement with Bayer for actinium-225 supply from Mol, Belgium location
• Schedule of Global Bioenergies' new biobased isobutene plant for cosmetics in France is specified.
• Agreement to Sell Athlone, Ireland Facility to Novo Nordisk Announced by Alkermes plc
• Expansion of production facilities in Chartres, France receives over 2.1 billion euros investment from Novo Nordisk.
• Novo Nordisk's investment in expansion of manufacturing facilities in Kalundborg, Denmark exceeds 5.6 billion Euro.
• Lonza Stein (CH) Introduces New Filling Line for Commercial Supply of Antibody-Drug Conjugates to Exclusive Customer
• BioNTech Strengthens Pioneering Position in AI-Powered Drug Discovery, Design, and Development with Completion of InstaDeep Acquisition
• Global Bioenergies raises ambitions for increased future isobutene plant sizing in France
• Novo Nordisk to invest €2.1bn in expanding manufacturing facilities in Hillerød, Denmark
• BASF boosts alkoxylates production capacity in Antwerp, Belgium, and Ludwigshafen, Germany
• WACKER strengthens its biotechnology business with the acquisition of ADL Biopharma in Leon, Spain
• Dexcom chooses Athenry Galway, Ireland as its first European manufacturing site.
• Lonza Finishes Manufacturing Line for Clinical and Commercial Drug Products in Visp (CH)
• Sandoz to Construct New Biologics Production Plant in Lendava, Slovenia, to Meet Growing Global Demand for Biosimilar Medicines
• Moderna chooses Harwell science campus in Oxfordshire for the establishment of its innovation and technology center in the UK.
• Getinge, a Swedish manufacturer, to set up UK headquarters in Derby.
• Expansion of Conjugation Facility in Visp, Switzerland Successfully Completed by Lonza
• Merck Enhances Manufacturing Capabilities in Molsheim, France with Over € 130 Million Investment
• MetaboGen and BioGaia inaugurate pilot plant for novel bacterial strains in Eslöv, Sweden
• Novartis plans to create a standalone company by separating Sandoz business through a 100% spin-off.
• Expansion of Carlow site planned by MSD Ireland
• Abbott Pours €430 Million into Expanding its Diabetes Operation in Kilkenny and Donegal, Ireland
• Sartorius strengthens its portfolio of innovative advanced therapy solutions with the acquisition of Albumedix
• Lonza Plans to Build a Large-Scale, Commercial Drug Product Fill & Finish Facility in Stein (CH)
• Moderna plans to establish a vaccine research and manufacturing centre in the UK.
• Large-scale production of sustainable fermentation-based antimicrobial peptides developed by mk2 Biotechnologies, WACKER, and TUM.